IP Verse

Kandy Therapeutics competitive analysis

Loading summary...

Latest patents of Kandy Therapeutics opposed by its competitors

Explore Kandy Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 30, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3765024
Nov 22, 2023Novel Pharmaceutical Formulation Comprising Dual Nk-1/Nk-3 Receptor Antagonists1
EP3574907
Aug 23, 2023An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent Diseases1

Latest PTAB cases involving Kandy Therapeutics

Discover the latest PTAB cases involving Kandy Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Kandy Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
KANDY THERAPEUTICS - 2 - -
AERA27 - - -